Search

everythinglearnresearchcommunity

for

Search:↓

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

A 5-year-old girl with a rare skin disorder was effectively treated with skin creams instead of oral medication.

Pimecrolimus reduces the effectiveness of stem cell therapy for atopic dermatitis.

Safusidenib erbumine shows promise as a treatment for certain brain tumors, but mild side effects like hair loss need attention.

Horizant has risks like other seizure drugs, Johnson & Johnson misled about Risperdal, and Quanterix found a possible link between brain oxygen loss and Alzheimer's markers.

Eating phenylthiocarbamide made all the rats' hair go gray, but some returned to their original color after stopping.

Tigason improved hair growth in a boy with monilethrix without side effects.

Cyclophosphamide is preferred for severe cases in pediatric rheumatology and nephrology despite its side effects.

Activated ras can protect kidney cells from a certain substance that causes cell death.

Some birth control pills increase blood clot risk; use them for specific conditions only.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Pallister-Killian Syndrome is a complex genetic disorder requiring coordinated care and genetic counseling.

Pazopanib treatment caused rapid hair color loss, possibly indicating its effectiveness.

Topical sulfonylurea may reduce excessive hair growth caused by certain medications.

Ritlecitinib was generally well tolerated in children with alopecia areata.

The treatment was effective for lupus nephritis with manageable side effects.

Applying a specific inhibitor lightens skin and hair color.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

Lenalidomide effectively and safely treats skin symptoms in pediatric lupus, reducing the need for prednisone.

Ruxolitinib can cause a delayed skin reaction on the nose.

Methotrexate is not proven effective for inducing remission in ulcerative colitis.

The rash resolved after stopping ponatinib.

Pesticides can cause reproductive and adrenal health issues.

Both penicillamine and tiopronin have significant side effects, but trying the alternative drug can be beneficial if the first is not tolerated.

A new, efficient method has been developed to detect darolutamide and thalidomide, drugs used for certain hair loss and prostate cancer treatments, in pharmaceuticals and body fluids.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

The FDA approved Litfulo® for treating severe alopecia areata in people aged 12 and older.